Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway

被引:86
|
作者
Fischer, Martin [1 ]
Uxa, Sigrid [1 ]
Stanko, Clara [1 ]
Magin, Thomas M. [2 ]
Engeland, Kurt [1 ]
机构
[1] Univ Leipzig, Med Sch, Mol Oncol, Leipzig, Germany
[2] Univ Leipzig, Ctr Regenerat Med, Inst Biol & Translat, Leipzig, Germany
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
RETINOBLASTOMA TUMOR-SUPPRESSOR; TYPE-16; E7; GROWTH ARREST; DREAM COMPLEX; TRANSCRIPTIONAL ACTIVATION; GENOMIC INSTABILITY; PROMOTER ELEMENTS; G(1) ARREST; HPV-16; B-MYB;
D O I
10.1038/s41598-017-02831-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
High risk human papilloma viruses cause several types of cancer. The HPV oncoproteins E6 and E7 are essential for oncogenic cell transformation. E6 mediates the degradation of the tumor suppressor p53, and E7 can form complexes with the retinoblastoma pRB tumor suppressor. Recently, it has been shown that HPV E7 can also interfere with the function of the DREAM transcriptional repressor complex. Disruption of DREAM-dependent transcriptional repression leads to untimely early expression of central cell cycle regulators. The p53-p21-DREAM pathway represents one important means of cell cycle checkpoint activation by p53. By activating this pathway, p53 can downregulate transcription of genes controlled by DREAM. Here, we present a genome-wide ranked list of genes deregulated by HPV E7 expression and relate it to datasets of cell cycle genes and DREAM targets. We find that DREAM targets are generally deregulated after E7 expression. Furthermore, our analysis shows that p53-dependent downregulation of DREAM targets is abrogated when HPV E7 is expressed. Thus, p53 checkpoint control is impaired by HPV E7 independently of E6. In summary, our analysis reveals that disruption of DREAM through the HPV E7 oncoprotein upregulates most, if not all, cell cycle genes and impairs p53' s control of cell cycle checkpoints.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway
    Martin Fischer
    Sigrid Uxa
    Clara Stanko
    Thomas M. Magin
    Kurt Engeland
    Scientific Reports, 7
  • [2] The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-α
    Barnard, P
    McMillan, NAJ
    VIROLOGY, 1999, 259 (02) : 305 - 313
  • [3] Distribution of Human Papilloma Virus-16 E7 oncoprotein in Iranian Patients with Cervix Cancer
    Piroozmand, Ahmad
    Jafariazad, Fateme
    Niakan, Mohammad
    Khaledi, Azad
    Piroozmand, Hale
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2018, 6 (02): : 354 - 359
  • [4] Effects of human papilloma virus oncoprotein E7 on antigen presentation and potential involvement of keratinocyte exosomes
    Budhwani, M.
    Jemon, K.
    Ly, K.
    Hibma, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 96 - 96
  • [5] Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer
    Chen, Tan-Hsia
    Huang, Chi-Chou
    Yeh, Kun-Tu
    Chang, Shu-Hau
    Chang, Shih-Wen
    Sung, Wen-Wei
    Cheng, Ya-Wen
    Lee, Huei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (30) : 4051 - 4058
  • [6] Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer
    Tan-Hsia Chen
    Chi-Chou Huang
    Kun-Tu Yeh
    Shu-Hau Chang
    Shih-Wen Chang
    Wen-Wei Sung
    Ya-Wen Cheng
    Huei Lee
    World Journal of Gastroenterology, 2012, (30) : 4051 - 4058
  • [7] Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein
    Eichten, A
    Westfall, M
    Pietenpol, JA
    Münger, K
    VIROLOGY, 2002, 295 (01) : 74 - 85
  • [8] Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7
    Ohlenschlaeger, O.
    Seiboth, T.
    Zengerling, H.
    Briese, L.
    Marchanka, A.
    Ramachandran, R.
    Baum, M.
    Korbas, M.
    Meyer-Klaucke, W.
    Duerst, M.
    Goerlach, M.
    ONCOGENE, 2006, 25 (44) : 5953 - 5959
  • [9] Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7
    O Ohlenschläger
    T Seiboth
    H Zengerling
    L Briese
    A Marchanka
    R Ramachandran
    M Baum
    M Korbas
    W Meyer-Klaucke
    M Dürst
    M Görlach
    Oncogene, 2006, 25 : 5953 - 5959
  • [10] The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19ARF
    Seavey, SE
    Holubar, M
    Saucedo, LJ
    Perry, ME
    JOURNAL OF VIROLOGY, 1999, 73 (09) : 7590 - 7598